A E Grzegorzewska



  1. Grzegorzewska A, Niepolski L, Świderska M, Mostowska A, Stolarek I, Warchoł W, et al. ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients. BMC Med Genet. 2018;19:194 pubmed publisher
    ..Differences in the availability of transcription binding sites may contribute to these associations. ..
  2. request reprint
    Grzegorzewska A, Młot Michalska M, Wobszal P. Does ingestion of regular coffee influence serum lipid profile in dialysis patients?. Adv Perit Dial. 2009;25:181-6 pubmed
  3. Grzegorzewska A, Pajzderski D, Sowińska A, Mostowska A, Jagodziński P. IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection. Vaccine. 2013;31:1766-70 pubmed publisher
    ..8%, CC 3.8%; IL13 CC 60.5%, CT 34.6%, TT 4.9%). In HD patients, neither the IL4R nor IL13 polymorphism is associated with anti-HBs development irrespective of whether an immunization is provoked by HBV vaccination or HBV infection. ..
  4. Grzegorzewska A, Cieszyński K, Niepolski L, Kaczmarek A, Sowińska A. Serum cardiac troponin T and effective blood flow in stable extracorporeal dialysis patients. Int Urol Nephrol. 2016;48:419-29 pubmed publisher
    ..In stable ED patients, higher eQB rates and QB/QD values might contribute to silent myocardial injury, particularly in patients with lower cTnT levels, but do not affect the outcome of ED patients. ..
  5. Grzegorzewska A, Kaczmarek Leki V, Młot Michalska M, Niepolski L. Seroconversion rate to positivity for antibodies against core antigen of hepatitis B virus and duration of renal replacement therapy. Nephrol Dial Transplant. 2011;26:970-6 pubmed publisher
    ..112, P = 0.04). Seroconversion rate to anti-HBc positivity is not related to duration of RRT treatment but to ineffective vaccination against HBV. ..
  6. Grzegorzewska A, Świderska M, Mostowska A, Warchoł W, Jagodziński P. Polymorphisms of T helper cell cytokine-associated genes and survival of hemodialysis patients - a prospective study. BMC Nephrol. 2017;18:165 pubmed publisher
    ..035). In multivariate analyses, however, the mentioned polymorphisms were not independent predictors of survival. Polymorphisms of IFNL3 rs8099917 and IL12A rs568408 contribute to survival of HD patients, but not as independent factors. ..
  7. Grzegorzewska A, Niepolski L, Mostowska A, Warchoł W, Jagodziński P. Involvement of adropin and adropin-associated genes in metabolic abnormalities of hemodialysis patients. Life Sci. 2016;160:41-46 pubmed publisher
    ..In HD patients, lower plasma adropin concentration is associated with dyslipidemia. Major homozygosity of RXRA seems to have an opposite effect on plasma adropin compared with that of ENHO rs2281997. ..
  8. request reprint
    Grzegorzewska A, Młot M. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease. Rocz Akad Med Bialymst. 2004;49:190-2 pubmed
    ..We checked correlation of CAP/CIP with osteoprotegrin (OPG), its soluble ligand (OPGL) and routinely measured parameters of bone turnover in patients treated with peritoneal dialysis (PD) and hemodialysis (HD)...
  9. request reprint
    Grzegorzewska A. [Metabolic syndrome in dialyzed patients. Advanced glycation end-products, adipocytokines, and principles of treatment]. Pol Merkur Lekarski. 2010;28:244-6 pubmed
    ..Attention was paid for therapeutic aspects, associated with treatment of end-stage renal disease and with dialysis procedure, which may influence the course of MeS...

More Information


  1. Grzegorzewska A, Wobszal P, Jagodziński P. Interleukin-18 promoter polymorphism and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients. Kidney Blood Press Res. 2012;35:1-8 pubmed publisher
    ..239 (95% CI 0.079-0.728, p = 0.010), and for CC versus TT it was 0.240 (95% CI 0.078-0.738, p = 0.009). In HD patients, the IL-18 -1297CC genotype may play a role in anti-HBsAg development in response to HBV surface antigen. ..
  2. Grzegorzewska A, Wobszal P, Mostowska A, Jagodziński P. Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients. BMC Nephrol. 2012;13:75 pubmed publisher
    ..6-fold lower chance for anti-HBs development than carriers of any other genotype (p = 0.042). Development of anti-HBs in HD patients is associated with gene polymorphisms of interleukins involved in the Th1 system. ..
  3. Grzegorzewska A, Wobszal P, Sowińska A, Mostowska A, Jagodziński P. Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection. Mol Biol Rep. 2013;40:6899-911 pubmed publisher
  4. Grzegorzewska A, Świderska M, Mostowska A, Warchoł W, Jagodziński P. Antibodies to HBV surface antigen in relation to interferon-?3 in hemodialysis patients. Vaccine. 2016;34:4866-4874 pubmed publisher
    ..103, 9-208, P=0.049). In HD patients, circulating IFN-?3 strongly correlates with anti-HBs production after HBV vaccination and infection. IFNL3 rs8099917 polymorphisms seem to be associated with IFN-?3 plasma levels in HD subjects. ..